tiprankstipranks
Trending News
More News >
Valerio Therapeutics (FR:ALVIO)
:ALVIO
France Market
Advertisement

Valerio Therapeutics (ALVIO) Income Statement

Compare
0 Followers

Valerio Therapeutics Income Statement

Last quarter (Q4 2024), Valerio Therapeutics's total revenue was €1.70M, an increase of 18.09% from the same quarter last year. In Q4, Valerio Therapeutics's net income was €-12.97M. See Valerio Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 1.79M€ 1.80M€ 1.44M€ 4.06M€ 1.78M
Gross Profit
€ 1.28M€ 1.27M€ 929.00K€ 3.69M€ -166.00K
Operating Expenses
€ 17.77M€ 21.55M€ 18.04M€ 9.26M€ 9.24M
Depreciation and Amortization
€ 11.31M€ 1.74M€ 33.00K€ 511.00K€ 654.00K
EBITDA
€ -12.06M€ -18.44M€ -17.04M€ -4.90M€ 2.33M
Operating Income
€ -16.49M€ -20.29M€ -17.11M€ -5.58M€ -7.81M
Other Income/Expenses
€ -7.06M€ -39.00K€ -2.55M€ -1.52M€ -348.00K
Pretax Income
€ -23.55M€ -20.33M€ -19.27M€ -6.66M€ 1.85M
Net Income
€ -23.93M€ -20.34M€ -19.56M€ -5.94M€ 1.09M
Per Share Metrics
Basic EPS
€ -0.16€ -0.15€ -0.18€ -0.07€ 0.01
Diluted EPS
€ -0.16€ -0.15€ -0.18€ -0.07€ 0.01
Weighted Average Shares Outstanding
153.88M 135.63M 105.75M 88.21M 73.15M
Weighted Average Shares Outstanding (Diluted)
153.88M 135.63M 105.75M 88.21M 75.87M
Currency in EUR

Valerio Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis